More Access and Evidence Articles

Access and Evidence

Gaining market access by providing value for money

Peter Mansell, (Jan 28, 2010)

Cost-effectiveness research will become more important as EU responsibility for the pharmaceutical sector moves to the Health and Consumer policy directorate, Lynne Taylor and Peter Mansell report.
Access and Evidence

Cracking the Chinese pharma market

Rajesh Chhabara, (Jan 28, 2010)

Access and Evidence

Better management means better market access

Peter Mansell, (Dec 14, 2009)

How to create unified market access strategies by fostering inter-departmental collaboration
Access and Evidence

Pharma at the tipping point I: Price versus value

Anonymous (not verified), (Oct 21, 2009)

A new report by consultants AT Kearney suggests current business models may soon become irrelevant.  How should pharma firms respond?
Access and Evidence

Egypt- Emerging Pharma Market? Part 1

nader.rizkalla, (Dec 17, 2008)

Egypt?! I bet your first thought will not be the pharmaceutical market.

Pages